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A 47-year-old man presented with epiphora and a mass around the lacrimal sac in his left eye. Imaging
studies revealed a favorable diagnosis of sinusitis-related mucocele. However, the pathological study of
the excised tumor demonstrated a diffuse large B cell lymphoma. The patient was consequently referred
to the oncology department for further management. Malignant lymphomas of the lacrimal sac are rare
and they can mimic mucoceles. As such, they should be included in the list of differential diagnoses for
lacrimal sac mass.
Copyright © 2014, The Ophthalmologic Society of Taiwan. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Tumors of the lacrimal sac are rare. Malignant lymphomas ac-
count for approximately 6% of all lacrimal sac tumors.1 They are
usually secondary to systemic lymphoreticular malignancies. Pri-
mary non-Hodgkin's lymphoma of the lacrimal sac is extremely
rare. Its symptoms are usually nonspeciﬁc, and thus easy to
misdiagnose. We report a patient with primary diffuse large B cell
lymphoma (DLBCL) of the lacrimal sac, which was initially mis-
diagnosed as a mucocele.2. Case report
A 47-year-old man with a history of chronic sinusitis pre-
sented with epiphora in his left eye for 4 months and had an
elastic mass around the left lacrimal sac for 2 months. The
ophthalmic examinations revealed an elastic, nontender, and
nonmovable mass around the left lacrimal sac (Fig. 1). Lacrimal
irrigation was patent. Orbital computed tomography (CT; Fig. 2A), Buddhist Tzu Chi General
g Road, 907 Hualien, Taiwan.
iety of Taiwan. Published by Elseviand magnetic resonance (MR) imaging (Fig. 2B and C) revealed
chronic paranasal sinusitis and a homogeneous cystic lesion
(17 mm  12 mm  20 mm) over the left lacrimal sac. The
radiologist suggested that sinusitis-related mucocele be ruled
out. The patient was then referred to an otolaryngologist. Func-
tional endoscopic sinus surgery and Monoka tube insertion were
performed. Polyps in the left osteomeatal complex and inﬂam-
matory contents over the left maxillary sinus opening were found
during the operation. The Monoka tube was inserted smoothly.
The pathological report showed chronic sinusitis only. However,
the epiphora persisted and the mass enlarged gradually. During
the tumor excision, a capsularized homogenous pink soft mass
over the lacrimal sac was observed. The lacrimal sac was totally
removed. The pathological results revealed a diffuse inﬁltration of
medium-size to large neoplastic cells with high mitotic activity
(Fig. 3A). The immunohistochemical stains showed the charac-
teristic CD20 (þ), CD3 (), CD5 (), and CK (), compatible with
the diagnosis of diffuse large B cell lymphoma (Fig. 3B). The pa-
tient was then referred to the oncology department. A whole-
body ﬂudeoxyglucose (FDG) positron emission tomography scan
demonstrated focal increased FDG uptake in the inferior medial
aspect of the left orbital cavity without metastasis (Fig. 4A). A
bone marrow examination revealed no bone marrow involve-
ment. The patient's serum lactate dehydrogenase (LDH) level
was 154 U/L. Six cycles of chemotherapy with rituximab,er Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
Fig. 1. There is an elastic, nontender, and nonmovable mass around left lacrimal sac
without inﬂammatory signs (arrow).
Fig. 4. (A) Whole-body ﬂudeoxyglucose positron emission tomography (FDG PET) scan
demonstrates focal increased FDG uptake in the inferior medial aspect of left orbital
cavity (arrow). (B) One year after rituximab, cyclophosphamide, doxorubicin, vincris-
tine, and prednisone (R-CHOP) therapy, no abnormal glucose metabolic region is found
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CHOP) were subsequently conducted. No abnormal glucose
metabolic region was found in the whole-body FDG positron
emission tomography scan 1 year after the chemotherapy
(Fig. 4B).in the whole-body FDG PET scan.3. Discussion
In clinical practice, one rarely encounters primary tumor of the
lacrimal sac. Among the recorded cases, 55% are considered ma-
lignant and 71% are of epithelial origin.1 Malignant lymphomas
account for approximately 6% of all lacrimal sac tumors.1 They are
usually secondary to systemic lymphoreticular malignancies. Pri-
mary non-Hodgkin's lymphoma of lacrimal sac is extremely rare in
the literature.2
Primary lacrimal sac lymphomas usually occur in elderly peo-
ple.2 Previous studies demonstrated that the 5-year overall survival
rate was about between 20% and 65% and showed a poor prognosisFig. 2. (A) Facial paranasal sinus computed tomography reveals a homogeneous high-de
thickening of the nasal cavity with polypoid lesions is also noted. (B) Head orbits postgadol
homogeneous lesion (17 mm  12 mm  20 mm) with contrast enhancement over left
hyperintense signal of the lesion.
Fig. 3. (A) Histopathological studies reveal diffuse inﬁltration of medium-sized to large neo
The immunohistochemical stain shows the neoplastic cells with CD20 (þ) (400).for patients with DLBCL involving the ocular adnexal region.2e4 The
symptoms are usually nonspeciﬁc, and therefore some were
initially misdiagnosed as dacryocystitis.3,4 In the present case, our
initial diagnosis was a mucocele. One report showed that a correct
and prompt diagnosis occurs in < 15% of cases with malignant
lacrimal sac tumors.5 Some patients were inadvertently diagnosed
during dacryocystorhinostomy or other procedures.6 Biopsy should
be conﬁrmed in lacrimal sac tumors. CT and MR images can aid in
making a deﬁnite diagnosis, staging, and planning treatment.5 The
mucocele or inﬂammatory dacryocystitis on CT scan displays a
nonenhancing homogenous mass with expansion of the bony wallsnsity cyst-like lesion over the left lacrimal sac (arrow). Marked periosteal mucosal
inium T1-weighted magnetic resonance imaging (MRI) reveals an iso- to hyperintense
lacrimal sac. Paranasal sinusitis is also noted. (C) T2-weighted MRI reveals slightly
plastic cells with high mitotic activity (arrow; hematoxylin and eosin stain, 400). (B)
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However, the lymphoma shows a hypointense signal on T2-
weighted images instead.5 Our case had a slightly hyperintense
lesion on T2 images. Moreover, the lesion was just adjacent to the
nasal cavity. Discriminating between mucoceles and lymphomas
using MR images may require pathological tests for conﬁrmation in
certain cases.
Meunier et al8 reported that certain factors, such as age (older
than 59 years), elevated LDH level, stage IV, high-grade histological
subgroup, and presence of B symptoms (fever, night sweats, and
weight loss), had a negative impact on the overall survival of pa-
tients with ocular non-Hodgkin's lymphoma. Rasmussen et al9
found that concordant bone marrow involvement was an inde-
pendent poor prognostic factor in ocular adnexal DLBCL. In the
present case, the patient was younger with normal LDH level and
had no bone marrow metastasis. His treatment prognosis is
favorable.
Systemic chemotherapy is effective in the treatment of localized
DLBCL.9 The recently introduced R-CHOP regimen has improved the
survival rate.10 Rituximab is a monoclonal chimeric anti-CD20
antibody that has been extensively used in treatment of B cell
non-Hodgkin's lymphoma.10 Its combination with chemotherapy
has a signiﬁcant beneﬁt compared with chemotherapy alone in
terms of response rate, progression-free survival, and overall sur-
vival in patients with DLBCLs.10
In conclusion, malignant lymphomas of the lacrimal sac are rare
and they can mimic mucoceles or dacryocystitis. A differential
diagnosis using neuroimages and biopsy is essential in making anaccurate diagnosis. The current treatment of choice for lacrimal sac
DLBCL is the R-CHOP regimen.References
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